0
0

Chapter 25. Agitation and Suspiciousness

Harold W. Goforth, M.D.; Lisa P. Gwyther, M.S.W.
DOI: 10.1176/appi.books.9781585623754.395768

Sections

Excerpt

Psychiatrists working with older adults frequently encounter suspicious or paranoid behaviors, especially in patients with agitation. In fact, such ideation is not very uncommon in community populations of elderly adults. In a community study of elderly persons in San Francisco, 17% of the subjects reported that they were highly suspicious, and 13% reported delusions (Lowenthal and Berkman 1967). Another study that included elderly persons in both urban and rural areas of North Carolina found that 4% of older adults experienced a sense of persecution by those around them (Christenson and Blazer 1984). Perceptions of a hostile social environment or ideas of persecution lead to greater stress, vigilance, and agitation among elderly persons, resulting in alienation from families and friends. Such individuals represent a challenge for clinicians who care for them.

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Table Reference Number
Table 25–1. Common medical causes of agitation in elderly persons

References

Alao AO, Soderberg M, Pohl EL, et al: Aripiprazole in the treatment of delirium. Int J Psychiatry Med 35:429–433, 2005
[PubMed]
 
Alexopoulos GS, Silver JM, Kahn DA, et al (eds): Agitation in Older Persons With Dementia: A Postgraduate Medicine Special Report (The Expert Consensus Guideline Series). New York, McGraw-Hill, 1998
 
Alzheimer's Association: Fact Sheet: About Agitation and Alzheimer's Disease. Chicago, IL, Alzheimer's Association, 2001. Available at http://www.nia.nih.gov/Alzheimers/Publications/adfact.htm. Accessed July 18, 2008.
 
Belle SH, Burgio L, Burns R, et al: Enhancing the quality of life of dementia caregivers from different ethnic and racial groups: a randomized, controlled trial. Ann Intern Med 145:727–738, 2006
[PubMed]
 
Bellelli G, Frisoni GB, Turco R, et al: Delirium superimposed on dementia predicts 12-month survival in elderly patients discharged from a postacute rehabilitation facility. J Gerontol A Biol Sci Med Sci 62:1306–1309, 2007
[PubMed]
 
Borson S, Raskind MA: Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease. Neurology 48 (suppl 6):S17–S24, 1997
 
Breitbart W, Tremblay A, Gibson C: An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 43:175–182, 2002
[PubMed]
 
Chen JC, Borson S, Scanlan JM: Stage-specific prevalence of behavioral symptoms in Alzheimer's disease in a multi-ethnic community sample. Am J Geriatr Psychiatry 8:123–133, 2000
[PubMed]
 
Chow TW, MacLean CH: Quality indicators for dementia in vulnerable community-dwelling and hospitalized elders. Ann Intern Med 135:668–676, 2001
[PubMed]
 
Christenson R, Blazer D: Epidemiology of persecutory ideation in an elderly population in the community. Am J Psychiatry 141:1088–1091, 1984
[PubMed]
 
Cohen-Mansfield J, Libin A, Marx MS: Nonpharmacological treatment of agitation: a controlled trial of systematic individualized intervention. J Gerontol A Biol Sci Med Sci 62:908–916, 2007
[PubMed]
 
Doody RS, Stevens JC, Beck C, et al: Practice parameter: management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56:1154–1166, 2001
[PubMed]
 
Gallicchio L, Siddiqui N, Langenberg P, et al: Gender differences in burden and depression among informal caregivers of demented elders in the community. Int J Geriatr Psychiatry 17:154–163, 2002
[PubMed]
 
Gauthier S, Loft H, Cummings J: Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis. Int J Geriatr Psychiatry 23:537–545, 2008
[PubMed]
 
Gwyther L: Family issues in dementia: finding a new normal. Neurol Clin 18:993–1010, 2000
[PubMed]
 
Gwyther L: Caring for People With Alzheimer's Disease: A Manual for Facility Staff. Washington, DC, American Health Care Association and Alzheimer's Association, 2001
 
Han CS, Kim YK: A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 45:297–301, 2004
[PubMed]
 
Hepburn K, Lewis M, Tomatore J, et al: The Savvy Caregiver Program: the effectiveness of a transportable dementia caregiver psychoeducational program. J Gerontol Nurs 33:30–36, 2007
[PubMed]
 
Herrmann N, Lanctôt KL: Do atypical antipsychotics cause stroke? CNS Drugs 19:91–103, 2005
[PubMed]
 
Inouye SK, Zhang Y, Jones RN, et al: Risk factors for delirium at discharge: development and validation of a predictive model. Arch Intern Med 167:1406–1413, 2007
[PubMed]
 
Kales HC, Valenstein M, Kim HM, et al: Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry 164:1568–1576, 2007
[PubMed]
 
Kiely DK, Jones RN, Bergmann MA, et al: Association between psychomotor activity delirium subtypes and mortality among newly admitted post-acute facility patients. J Gerontol A Biol Sci Med Sci 62:174–179, 2007
[PubMed]
 
Layton D, Harris S, Wilton LV, et al: Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia. J Psychopharmacol 19:473–482, 2005
[PubMed]
 
Lemke MR: Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics. J Clin Psychiatry 56:354–357, 1995
[PubMed]
 
Leso L, Schwartz TL: Ziprasidone treatment of delirium. Psychosomatics 43:61–62, 2002
[PubMed]
 
Levkoff S, Cleary P, Liptzin B, et al: Epidemiology of delirium: an overview of research issues and findings. Int Psychogeriatr 3:149–167, 1991
[PubMed]
 
Levy ML, Cummings JL, Kahn-Rose R: Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease. Gerontology 45 (suppl 1):15–22, 1999
 
Lipowski ZJ: Delirium in the elderly patient. N Engl J Med 320:578–582, 1989
[PubMed]
 
Little JT, Satlin A, Sunderland T, et al: Sundown syndrome in severely demented patients with probable Alzheimer's disease. J Geriatr Psychiatry Neurol 8:103–106, 1995
[PubMed]
 
Logsdon RG, McCurry SM, Teri L: Evidence-based psychological treatments for disruptive behaviors in individuals with dementia. Psychol Aging 22:28–36, 2007
[PubMed]
 
Lowenthal MF, Berkman PL: Aging and Mental Disorders in San Francisco: A Social Psychiatry Study. San Francisco, CA, Jossey-Bass, 1967
 
Lyketsos CG, Steinberg M, Tschanz JT, et al: Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry 157:708–714, 2000
[PubMed]
 
McCusker J, Cole M, Dendukuri N, et al: Delirium in older medical inpatients and subsequent cognitive and functional status: a prospective study. CMAJ 165:575–583, 2001
[PubMed]
 
Narayan M, Nelson JC: Treatment of dementia with behavioral disturbance using divalproex or a combination of divalproex and a neuroleptic. J Clin Psychiatry 58:351–354, 1997
[PubMed]
 
Opler LA, Feinberg SS: The role of pimozide in clinical psychiatry: a review. J Clin Psychiatry 52:221–233, 1991
[PubMed]
 
Pae CU, Lee SJ, Lee CU, et al: A pilot trial of quetiapine for the treatment of patients with delirium. Hum Psychopharmacol 19:125–127, 2004
[PubMed]
 
Raivio MM, Laurila JV, Strandberg TE, et al: Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study. Am J Geriatr Psychiatry 15:416–424, 2007
[PubMed]
 
Rea RS, Battistone S, Fong JJ, et al: Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy 27:588–594, 2007
[PubMed]
 
Sasaki Y, Matsuyama T, Inoue S, et al: A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiatry 64:1316–1321, 2003
[PubMed]
 
Shankle WR, Nielson KA, Cotman CW: Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients. Alzheimer Dis Assoc Disord 9:233–237, 1995
[PubMed]
 
Small GW, Rabins PV, Barry PP, et al: Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 278:1363–1371, 1997
[PubMed]
 
Snyder L: Perspectives: A Newsletter for Individuals Diagnosed With Alzheimer's Disease. Alzheimer's Disease Research Center, University of California, San Diego, 2001, p 2
 
Soares JC, Gershon S: Therapeutic targets in late-life psychoses: review of concepts and critical issues. Schizophr Res 27:227–239, 1997
[PubMed]
 
Tariot PN, Erb R, Podgorski CA, et al: Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 155:54–61, 1998
[PubMed]
 
Teri L: Behavior and caregiver burden: behavioral problems in patients with Alzheimer disease and its association with caregiver burden. Alzheimer Dis Assoc Disord 11 (suppl 4):S35–S38, 1997
 
Teri L, Huda P, Gibbons L, et al: STAR: a dementia-specific training program for staff in assisted living residences. Gerontologist 45:686–693, 2005
[PubMed]
 
Tractenberg RE, Garmst A, Weiner MF, et al: Frequency of behavioral symptoms characterizes agitation in Alzheimer's disease. Int J Geriatr Psychiatry 16:886–891, 2001
[PubMed]
 
Yassa R, Suranyi-Cadotte B: Clinical characteristics of late-onset schizophrenia and delusional disorder. Schizophr Bull 19:701–707, 1993
[PubMed]
 
+

CME Activity

Add a subscription to complete this activity and earn CME credit.
Sample questions:
1.
Kraepelin used the term paraphrenia to describe older patients who today would be most likely diagnosed according to DSM-IV-TR as having
2.
You ask the resident with whom you are working to outline some common nonpharmacological strategies for reducing agitation in an elderly patient whom you are treating. She comes up with the list below. You feel that all are good strategies except
3.
There are a number of communication strategies that may reduce a person's agitation. Which of the following is an example of one of these strategies?
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 37.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 3.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 7.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 9.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 11.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation